Can Artificial Intelligence Accurately Forecast Drug Trial Outcomes?

Boston, Monday, 26 October 2026.
Insilico Medicine launched inClinico Agent today, achieving 78% Phase 3 accuracy to predict trial outcomes and compress months of clinical landscape analysis into minutes for pharmaceutical developers.